$NVMI

Simon Zehava sold $456K of NVMI

Simon Zehava sold 820 shares of NOVA LTD. (NVMI) at an average of $556.46 ($536.52–$581.20, $0.46M total) across 2 trades over 2026-06-22 to 2026-06-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Simon Zehava
Published Jun 24, 2026, 6:36 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 6:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$NVMI
Neutral
medium confidence
Mentioned
$NVMI
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NVMINeutralLow
01

Why it matters

The disclosed sale amount ($456.3K) and share prices ($536.52–$581.20) provide transparency on insider behavior, but the filing does not include any new company performance or strategic developments.

02

Market read

Use as a sentiment/positioning input rather than a standalone fundamental catalyst.

03

What to watch

Traders may over-weight single insider sales; without concurrent news (earnings, guidance, contracts), the signal is typically weak.

Relevance 3/10Novelty 5/10Timing: today’s SEC Form 4 filing (filed 2026-06-24) discloses the 6/22–6/23 sale details

Background

The article is an SEC Form 4 insider transaction disclosure for NOVA Ltd. (NVMI) by director Simon Zehava.

Company-level read

Ticker impact

$NVMINeutralMedium confidence
Context

NOVA Ltd. (NVMI) disclosed via SEC Form 4 that director Simon Zehava sold $456.3K of NVMI shares under a 10b5-1 plan on 6/22–6/23.

Expected impact

Likely limited near-term impact; any effect should be small and transient unless followed by additional disclosures.

Evidence & confidence

The filing is a routine Form 4 transaction with a pre-arranged 10b5-1 plan and no accompanying operational or financial guidance changes in the text.

Market effects

No sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish information.

Key entities

  • NOVA Ltd.

    Company whose shares were sold; subject of the Form 4 insider transaction.

  • Simon Zehava

    Director who executed the open-market sale under a 10b5-1 plan.

Related articles

$TEVAMed

Wed: Teva jumps but TASE continues to lose ground

Globes reports the Tel Aviv Stock Exchange fell on July 29, with the Tel Aviv 35 down 0.99% and Tel Aviv 125 down 0.96%. Teva Pharmaceutical (NYSE: TEVA; TASE: TEVA) rose 10.17% after Q2 results and raised revenue guidance. Other movers included Enlight Renewable Energy, Elbit Systems, and banks such as Bank Leumi and Hapoalim.

$NVMIMed

Nova WMC™ Expanding Adoption Across the Most Advanced Packaging Processes

Nova (NASDAQ: NVMI) said a leading global foundry customer selected its Nova WMC™ platform as tool-of-record for multi-layer measurement in advanced packaging. The company expects the win to support multiple production flows and notes accelerating WMC™ adoption across memory and foundry customers. Nova cited modular design and nanometer-level large-area scanning throughput.

$TSEMMed

Mon: TASE suffers biggest falls since October 8, 2023

Israel’s Tel Aviv Stock Exchange fell sharply after Iran halted talks with the US over escalation in Lebanon, according to the report. The Tel Aviv 35 Index dropped 4.21% to 4,268.02 and Tel Aviv 125 fell 4.31% to 4,239.39. Turnover was NIS 5.91b in equities and NIS 6.31b in bonds. Tower Semiconductor led losses (-13.99%).